Boe Technology Group Co., Ltd.
Clinical trials sponsored by Boe Technology Group Co., Ltd., explained in plain language.
-
Donor cells join fight against advanced cancers
Disease control Not yet recruitingThis early study tests whether adding donor natural killer (NK) cells to standard maintenance therapy can safely help control advanced lung and colorectal cancers. About 20 adults will receive NK cell infusions alongside their usual drugs. The main goal is to check for side effec…
Phase: PHASE1, PHASE2 • Sponsor: BOE Technology Group Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Umbilical cord stem cells tested in stroke patients
Disease control Not yet recruitingThis early-stage trial tests whether stem cells from human umbilical cords are safe and might help people recover from a severe stroke. About 35 adults who had a stroke within the last 48 hours will receive either the stem cells or a placebo. The study will check for side effects…
Phase: PHASE1 • Sponsor: BOE Technology Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC